Rezdiffra

News

Madrigal eyes combination MASH therapy with Pfizer deal

Madrigal Pharma is reheating a drug for metabolic dysfunction-associated steatohepatitis (MASH) put on ice by Pfizer last year.

News

Madrigal closes on EU approval of first MASH treatment

Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.

News

Madrigal Pharma is first over the MASH finish line

Madrigal Pharma has become the first drugmaker to claim FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH), an elusive target that ha

Madrigal eyes combination MASH therapy with Pfizer deal

Madrigal closes on EU approval of first MASH treatment

Madrigal Pharma is first over the MASH finish line

Manufacturing issues mar ITM's radiopharma filing, says FDA

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks